BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 29653029)

  • 1. Prostate-specific membrane antigen-targeted photoacoustic imaging of prostate cancer in vivo.
    Zhang HK; Chen Y; Kang J; Lisok A; Minn I; Pomper MG; Boctor EM
    J Biophotonics; 2018 Sep; 11(9):e201800021. PubMed ID: 29653029
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [(18)F]Fluoroethyl Triazole Substituted PSMA Inhibitor Exhibiting Rapid Normal Organ Clearance.
    Chen Y; Lisok A; Chatterjee S; Wharram B; Pullambhatla M; Wang Y; Sgouros G; Mease RC; Pomper MG
    Bioconjug Chem; 2016 Jul; 27(7):1655-62. PubMed ID: 27270097
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor Uptake of Triazine Dendrimers Decorated with Four, Sixteen, and Sixty-Four PSMA-Targeted Ligands: Passive versus Active Tumor Targeting.
    Lim J; Guan B; Nham K; Hao G; Sun X; Simanek EE
    Biomolecules; 2019 Aug; 9(9):. PubMed ID: 31466360
    [TBL] [Abstract][Full Text] [Related]  

  • 4.
    Banerjee SR; Foss CA; Horhota A; Pullambhatla M; McDonnell K; Zale S; Pomper MG
    Biomacromolecules; 2017 Jan; 18(1):201-209. PubMed ID: 28001364
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A PSMA-targeted theranostic agent for photodynamic therapy.
    Chen Y; Chatterjee S; Lisok A; Minn I; Pullambhatla M; Wharram B; Wang Y; Jin J; Bhujwalla ZM; Nimmagadda S; Mease RC; Pomper MG
    J Photochem Photobiol B; 2017 Feb; 167():111-116. PubMed ID: 28063300
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeted Nanobubbles Carrying Indocyanine Green for Ultrasound, Photoacoustic and Fluorescence Imaging of Prostate Cancer.
    Wang Y; Lan M; Shen D; Fang K; Zhu L; Liu Y; Hao L; Li P
    Int J Nanomedicine; 2020; 15():4289-4309. PubMed ID: 32606678
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MRI Assessment of Prostate-Specific Membrane Antigen (PSMA) Targeting by a PSMA-Targeted Magnetic Nanoparticle: Potential for Image-Guided Therapy.
    Ngen EJ; Benham Azad B; Boinapally S; Lisok A; Brummet M; Jacob D; Pomper MG; Banerjee SR
    Mol Pharm; 2019 May; 16(5):2060-2068. PubMed ID: 30912947
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dual contrast agents for fluorescence and photoacoustic imaging: evaluation in a murine model of prostate cancer.
    Lesniak WG; Wu Y; Kang J; Boinapally S; Ray Banerjee S; Lisok A; Jablonska A; Boctor EM; Pomper MG
    Nanoscale; 2021 May; 13(20):9217-9228. PubMed ID: 33978042
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prostate Cancer Targeted X-Ray Fluorescence Imaging via Gold Nanoparticles Functionalized With Prostate-Specific Membrane Antigen (PSMA).
    Hara D; Tao W; Totiger TM; Pourmand A; Dogan N; Ford JC; Shi J; Pollack A
    Int J Radiat Oncol Biol Phys; 2021 Sep; 111(1):220-232. PubMed ID: 33964351
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo imaging of prostate cancer using an anti-PSMA scFv fragment as a probe.
    Mazzocco C; Fracasso G; Germain-Genevois C; Dugot-Senant N; Figini M; Colombatti M; Grenier N; Couillaud F
    Sci Rep; 2016 Mar; 6():23314. PubMed ID: 26996325
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and Biologic Evaluation of Novel 18F-Labeled Probes Targeting Prostate-Specific Membrane Antigen for PET of Prostate Cancer.
    Harada N; Kimura H; Onoe S; Watanabe H; Matsuoka D; Arimitsu K; Ono M; Saji H
    J Nucl Med; 2016 Dec; 57(12):1978-1984. PubMed ID: 27417647
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 99mTc-labeled small-molecule inhibitors of prostate-specific membrane antigen for molecular imaging of prostate cancer.
    Hillier SM; Maresca KP; Lu G; Merkin RD; Marquis JC; Zimmerman CN; Eckelman WC; Joyal JL; Babich JW
    J Nucl Med; 2013 Aug; 54(8):1369-76. PubMed ID: 23733925
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Robotic real-time near infrared targeted fluorescence imaging in a murine model of prostate cancer: a feasibility study.
    Laydner H; Huang SS; Heston WD; Autorino R; Wang X; Harsch KM; Magi-Galluzzi C; Isac W; Khanna R; Hu B; Escobar P; Chalikonda S; Rao PK; Haber GP; Kaouk JH; Stein RJ
    Urology; 2013 Feb; 81(2):451-6. PubMed ID: 23374828
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prostate-Specific Membrane Antigen Targeted Deep Tumor Penetration of Polymer Nanocarriers.
    Meher N; Ashley GW; Bidkar AP; Dhrona S; Fong C; Fontaine SD; Beckford Vera DR; Wilson DM; Seo Y; Santi DV; VanBrocklin HF; Flavell RR
    ACS Appl Mater Interfaces; 2022 Nov; 14(45):50569-50582. PubMed ID: 36318757
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Full preclinical validation of the 123I-labeled anti-PSMA antibody fragment ScFvD2B for prostate cancer imaging.
    Frigerio B; Franssen G; Luison E; Satta A; Seregni E; Colombatti M; Fracasso G; Valdagni R; Mezzanzanica D; Boerman O; Canevari S; Figini M
    Oncotarget; 2017 Feb; 8(7):10919-10930. PubMed ID: 28051996
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prostate-specific membrane antigen (PSMA)-targeted photodynamic therapy enhances the delivery of PSMA-targeted magnetic nanoparticles to PSMA-expressing prostate tumors.
    Ngen EJ; Chen Y; Azad BB; Boinapally S; Jacob D; Lisok A; Shen C; Hossain MS; Jin J; Bhujwalla ZM; Pomper MG; Banerjee SR
    Nanotheranostics; 2021; 5(2):182-196. PubMed ID: 33564617
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PSMA-targeted contrast agents for intraoperative imaging of prostate cancer.
    Bao K; Lee JH; Kang H; Park GK; El Fakhri G; Choi HS
    Chem Commun (Camb); 2017 Feb; 53(10):1611-1614. PubMed ID: 28085163
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dual-Modality Image-Guided Surgery of Prostate Cancer with a Radiolabeled Fluorescent Anti-PSMA Monoclonal Antibody.
    Lütje S; Rijpkema M; Franssen GM; Fracasso G; Helfrich W; Eek A; Oyen WJ; Colombatti M; Boerman OC
    J Nucl Med; 2014 Jun; 55(6):995-1001. PubMed ID: 24700882
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of PSMA-Targeted PAMAM Dendrimer Nanoparticles in a Murine Model of Prostate Cancer.
    Lesniak WG; Boinapally S; Banerjee SR; Behnam Azad B; Foss CA; Shen C; Lisok A; Wharram B; Nimmagadda S; Pomper MG
    Mol Pharm; 2019 Jun; 16(6):2590-2604. PubMed ID: 31002252
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preclinical Evaluation of
    Cardinale J; Schäfer M; Benešová M; Bauder-Wüst U; Leotta K; Eder M; Neels OC; Haberkorn U; Giesel FL; Kopka K
    J Nucl Med; 2017 Mar; 58(3):425-431. PubMed ID: 27789722
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.